|MANGANESE||ICSC: 0174 (November 2003)|
| CAS #: 7439-96-5
|EC Number: 231-105-1
|ACUTE HAZARDS||PREVENTION||FIRE FIGHTING|
|FIRE & EXPLOSION||Combustible. Finely dispersed particles form explosive mixtures in air.||NO open flames. Closed system, dust explosion-proof electrical equipment and lighting. Prevent deposition of dust.||Use dry sand, special powder.|
|PREVENT DISPERSION OF DUST! AVOID EXPOSURE OF (PREGNANT) WOMEN!|
|Inhalation||Cough.||Use local exhaust or breathing protection.||Fresh air, rest. Refer for medical attention.|
|Skin||Protective gloves.||Rinse and then wash skin with water and soap.|
|Eyes||Wear safety goggles or eye protection in combination with breathing protection if powder.||First rinse with plenty of water for several minutes (remove contact lenses if easily possible), then refer for medical attention.|
|Ingestion||Abdominal pain. Nausea.||Do not eat, drink, or smoke during work.||Rinse mouth. Refer for medical attention .|
|SPILLAGE DISPOSAL||CLASSIFICATION & LABELLING|
|Personal protection: particulate filter respirator adapted to the airborne concentration of the substance. Sweep spilled substance into covered containers. Carefully collect remainder. Then store and dispose of according to local regulations.||
According to UN GHS Criteria
|Separated from acids. Dry.|
|PHYSICAL & CHEMICAL INFORMATION|
Physical State; Appearance
|EXPOSURE & HEALTH EFFECTS|
Routes of exposure
Effects of short-term exposure
Effects of long-term or repeated exposure
|OCCUPATIONAL EXPOSURE LIMITS|
TLV: (respirable fraction): 0.02 mg/m3, as TWA.
TLV: (inhalable fraction): 0.1 mg/m3, as TWA.
TLV: A4 (not classifiable as a human carcinogen).
EU-OEL: (inhalable fraction): 0.2 mg/m3 as TWA.
EU-OEL: (respirable fraction): 0.05 mg/m3 as TWA.
MAK: (inhalable fraction): 0.2 mg/m3; (respirable fraction): 0.02 mg/m3; peak limitation category: II(8); pregnancy risk group: C
|This substance may be hazardous to the environment. Special attention should be given to aquatic organisms.|
|Depending on the degree of exposure, periodic medical examination is suggested.
The recommendations on this Card also apply to ferro manganese.
|All rights reserved. The published material is being distributed without warranty of any kind, either expressed or implied. Neither ILO nor WHO nor the European Commission shall be responsible for the interpretation and use of the information contained in this material.|